...
首页> 外文期刊>BMC Public Health >Everything counts - a method to determine viral suppression among people living with HIV using longitudinal data for the HIV care continuum - results of two large, German, multi-center real-life cohort studies over 20?years (1999–2018)
【24h】

Everything counts - a method to determine viral suppression among people living with HIV using longitudinal data for the HIV care continuum - results of two large, German, multi-center real-life cohort studies over 20?years (1999–2018)

机译:一切都很重要 - 一种测定与艾滋病毒的人们使用纵向数据,用于艾滋病毒护理连续体的病毒抑制的方法 - 结果两大,德国,多中心现实队员研究超过20?年(1999-2018)

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Abstract Background The aim of this study was to develop a standardized method to reconstruct persons’ individual viral load (VL) courses to determine viral suppression and duration of viremia for the HIV care continuum in Germany using longitudinal cohort data. Methods We analyzed data from two large, multi-center German cohort studies under the direction of the Robert Koch Institute. We included data from 1999 to 2018 of all diagnosed people and of people who initiated antiretroviral treatment (ART). We developed a model generating virtual VL values and an individual VL course corresponding to real VL measurements with a maximum distance of 180?days, considering ART status and VL dynamics. If the distance between VL measurements was ?180?days, the time between was defined as gap time. Additionally, we considered blips, which we defined as a single detectable VL ?1000 copies/ml decreased from 37% in 1999 to 3% in 2018. The proportion of people with gap time fluctuated and ranged between 18 and 28%. An analysis of the first VL after gap time showed that 90% showed viral suppression, 5% VL between 50-??1000 copies/ml. Conclusion We provide a method for estimating viral suppression and duration of viremia using longitudinal VL data. We observed a continuous and remarkable increase of viral suppression. Furthermore, a notable proportion of those with viremia showed low-level viremia and were therefore unlikely to transmit HIV. Individual health risks and HIV drug resistance among those with low-level viremia are problematic, and viral suppression remains the goal. In 2018, 93 and 96% of people after ART initiation showed VL ?50 copies/ml and VL ?200 copies/ml, respectively. Therefore, using the threshold of VL ?200 copies/ml, Germany reached the UNAIDS 95 target of viral suppression since 2017.
机译:摘要背景本研究的目的是开发一种标准化的方法,以重建人类个体病毒载量(VL)课程,以确定德国艾滋病毒护理连续体的病毒抑制和贫血血症的持续时间使用纵向队列数据。方法在Robert Koch Institute的指导下分析了两次大型多中心德国队列研究的数据。我们包括1999年至2018年所有诊断的人和发起抗逆转录病毒治疗(艺术)的人的数据。我们开发了一个模型生成虚拟VL值和与真实VL测量相对应的单独VL课程,其最大距离为180?天,考虑艺术状态和VL动态。如果VL测量之间的距离是& 180?天,则被定义为差距时间。此外,我们认为我们定义为单个可检测的VL?1000份/ ml在1999年的37%下降至2018年的3%。差距时间波动的人数波动,范围为18%至28%。间隙时间后第一VL的分析表明90%显示病毒抑制,5%VL在50 - 约克1000℃/ mL之间。结论我们提供了一种使用纵向VL数据估算病毒抑制和病毒血症的持续时间。我们观察到病毒抑制的连续和显着增加。此外,患有病毒血症的显着比例显示出低水平的病毒血症,因此不太可能传播艾滋病毒。具有低级别病毒血症的个人健康风险和艾滋病毒毒性抗性是有问题的,并且病毒抑制仍然是目标。 2018年,93和96%的人在艺术启动后显示VL& 50拷贝/ ml和v1。200拷贝/ ml。因此,使用VL的阈值,德国自2017年以来达到了艾滋病规划署95型病毒镇压的统计学目标。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号